eFFECTOR Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
eFFECTOR Therapeutics, Inc.
CIK #0001577561, 0001828522
EDGAR Form CIK 2011 - 2025
D [0001577561]
10-K [0001828522]
10-Q [0001828522]
3 [0001828522]
4 [0001828522]
8-K [0001828522]
SC 13D [0001828522]
SC 13G [0001828522]
Form 13D/13G Filer Form 13D/13G Subject Filed
Altitude Life Science Ventures Fund II LP Effector Therapeutics Inc [2023-03-07]
SR One Capital Management LLC Effector Therapeutics Inc [2022-02-14]
Pfizer Inc Effector Therapeutics Inc [2022-02-14]
Sectoral Asset Management Inc Effector Therapeutics Inc [2022-02-11]
US Venture Partners X LP Effector Therapeutics Inc [2021-09-13]
Column Group II LP Effector Therapeutics Inc [2021-09-07]
Abingworth LLP Effector Therapeutics Inc [2021-09-03]
Beryl Capital Management LLC Locust WALK Acquisition Corp [2021-08-20]
FEIS Lawrence Michael Locust WALK Acquisition Corp [2021-08-17]
Linden Capital LP Locust WALK Acquisition Corp [2021-02-08]
Empyrean Capital Partners LP Locust WALK Acquisition Corp [2021-01-21]
Form 3/4/5 Subject 2011 - 2025
eFFECTOR Therapeutics, Inc.
Klencke Barbara
Bhatt Elizabeth
Gallagher Brian M. Jr.
Harrington-Smith Kristen
Ehrlich Christopher B
Loewy Caroline M
Worland Stephen T
Byrnes Michael
Warner Douglas J
View All
Terms | Privacy | Guide
tony@aum13f.com